Nektar Therapeutics (MM) Stock Price - NKTR

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$31.00
CHART Trader
Monthly Subscription
for only
$27.87
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$60.99
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Nektar Therapeutics (MM) NKTR NASDAQ Common Stock US6402681083
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.155 -0.79% 19.58 19.74 19.27 19.74 19.735 09:42:15
Bid Price Ask Price Spread Spread % News
19.54 19.63 0.09 0.46% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
101 18,716 $ 19.5613 $ 366.11k 1.47M 11.41 - 24.88
Last Trade Time Type Quantity Stock Price Currency
09:42:09 2 $19.58 USD
Industry Sector
Biotechnology

Nektar Therapeutics (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.04B 155.15M $ -153.52M -1.10 0.00 88.71M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
10.48M $ 0.00 0.00% -16.47k 94.90%

more financials information »

Nektar Therapeutics (MM) News

Latest NKTR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NKTR Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week18.5420.2818.090.0000616k1M917k1.045.61%
1 Month20.8821.10517.590.0000616k3M1M-1.3-6.23%
3 Months22.823.1417.330.0000544k4M2M-3.22-14.12%
6 Months12.924.8811.410.0000241k15M2M6.6851.78%
1 Year13.5824.8811.410.0000241k15M1M644.18%
3 Years12.8324.889.160.0000015M1M6.7552.61%
5 Years8.1624.885.650.0000015M1M11.42139.95%

Nektar Therapeutics (MM) Description

Nektar Therapeutics, Inc, is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.